The Relationship between Functional Promoter Variants of Macrophage Migration Inhibitory Factor and Endometriosis

被引:6
|
作者
Chekini, Zahra [1 ,2 ]
Shahhoseini, Maryam [3 ,4 ]
Aflatoonian, Reza [2 ]
Afsharian, Parvaneh [4 ]
机构
[1] Islamic Azad Univ, Dept Biol, Sci & Res Branch, Tehran, Iran
[2] ACECR, Royan Inst Reprod Biomed, Dept Endocrinol & Female Infertil, Reprod Biomed Res Ctr, POB 16635-148, Tehran, Iran
[3] ACECR, Royan Inst Reprod Biomed, Reprod Epidemiol Res Ctr, Tehran, Iran
[4] ACECR, Royan Inst Reprod Biomed, Dept Genet, Reprod Biomed Res Ctr, POB 16635-148, Tehran, Iran
关键词
Endometriosis; Gene Expression; Haplotype; Macrophage Migration Inhibitory Factor; Polymorphism; FACTOR MIF; POLYMORPHISM; EXPRESSION; GENE; SUSCEPTIBILITY; ASSOCIATION; HAPLOTYPE; MUTATION; SHESIS; CELLS;
D O I
10.22074/cellj.2021.6858
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: Endometriosis is a common gynecological and inflammatory disorder. Macrophage migration inhibitory factor (MIF) is a key pro-inflammatory cytokine that is secreted by accumulated active macrophages in ectopic endometrial tissues. Two promoter polymorphisms of MIF [-794(CATT)(5-8)/-173G/C] were identified to susceptibility and severity of several immune and inflammatory diseases. We aimed to evaluate the possible association between MIF promoter polymorphisms and susceptibly to endometriosis and its corolation with mRNA level. Materials and Methods: This case-control study was performed in Royan Institute from 2015 to 2017. Polymorphisms were evaluated in 106 endometriosis patients and 110 controls. For 17 endometrioma tissues, gene expression studies were conducted during secretory phase of menstrual cycle. Restriction fragment length polymorphism (RFLP) analysis was performed to determine -173G/C polymorphism and -794(CATT)(5-8) were detected by sequencing. Quantitative polymerase chain reaction (Q-PCR) was carried out to determine MIF expression level. Results: Homozygote of CATT(7) was observed only in endometriosis whilst we did not detect the significant allele and genotype variation in both groups. The homozygotes for -794(CATT)(5-8) and -173G/C polymorphisms were obtained to estimate the haplotype frequencies. Significantly higher haplotype frequencies were observed for CATT(5)/G in controls [global P value=0.044]. Additionally, the CATT(5)/C and CATT(7)/G haplotypes were not detected in any groups. Expression level of mRNA in ectopic tissue of endometriosis patients with CATT(6,7)/CC haplotype, were significantly higher compared to other haplotypes including CATT(5,5)/GG (2.91 fold, P=0.007), CATT(5,5)/GC (2.48 fold, P=0.047) and CATT(6,6)/GG (2.08 fold, P=0.046). Conclusion: We report, for the first time, a strong linkage between the decreased repetition of CATT and G allele in control and CATT(6)/C and CATT(7)/C haplotypes in endometriosis patients. Increased MIF expression is affected by genetic variants in the MIF promoter in ectopic endometrial tissues. This promoter haplotype might play an important role in the development and establishment of endometriosis.
引用
收藏
页码:450 / 456
页数:7
相关论文
共 50 条
  • [1] Association between macrophage migration inhibitory factor in the endometrium and estrogen in endometriosis
    Zhang, Xiao
    Mu, Lin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (02) : 787 - 791
  • [2] Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases
    Shiroeda, Hisakazu
    Tahara, Tomomitsu
    Shibata, Tomoyuki
    Nakamura, Masakatsu
    Yamada, Hideto
    Nomura, Tomoe
    Hayashi, Ranji
    Saito, Takashi
    Fukuyama, Tomoki
    Otsuka, Toshimi
    Yano, Hirokazu
    Ozaki, Kazuaki
    Tsuchishima, Mutsumi
    Tsutsumi, Mikihiro
    Arisawa, Tomiyasu
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 (05) : 707 - 709
  • [3] Gastric cancer susceptibility in gastric cancer relatives: Attributable risks of Macrophage migration inhibitory factor promoter polymorphism and Helicobacter pylori
    Li, Haixia
    Zang, Jing
    Wang, Peng
    Dai, Liping
    Zhang, Jianying
    Wang, Kaijuan
    CYTOKINE, 2012, 60 (02) : 346 - 351
  • [4] Association of macrophage migration inhibitory factor promoter polymorphism-173G/C with susceptibility to childhood asthma
    El-Adly, Tarek Z.
    Kamal, Sally
    Selim, Hala
    Botros, Shahira
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 41 (03) : 268 - 272
  • [5] Macrophage migration inhibitory factor as a potential biomarker of endometriosis
    Mahdian, Soodeh
    Aflatoonian, Reza
    Yazdi, Reza Salman
    Yaghmaei, Parichehr
    Ramazanali, Fariba
    Afsharian, Parvaneh
    Shahhoseini, Maryam
    FERTILITY AND STERILITY, 2015, 103 (01) : 153 - +
  • [6] Association between macrophage migration inhibitory factor rs1007888 and GDM
    Zhan, Y.
    Li, C.
    Chen, J.
    Yu, S.
    Gao, Q.
    Wang, Y. P.
    Liu, S. G.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (01) : 797 - 804
  • [7] Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis
    Savva, Athina
    Brouwer, Matthijs C.
    Roger, Thierry
    Seron, Mercedes Valls
    Le Roy, Didier
    Ferwerda, Bart
    van der Ende, Arie
    Bochud, Pierre-Yves
    van de Beek, Diederik
    Calandra, Thierry
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (13) : 3597 - 3602
  • [8] Functional characterization of the turkey macrophage migration inhibitory factor
    Park, Myeongseon
    Kim, Sungwon
    Fetterer, Raymond H.
    Dalloul, Rami A.
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2016, 61 : 198 - 207
  • [9] Macrophage migration inhibitory factor and its relationship with obesity and diabetes.
    Matia-Garcia, Ines
    de la Cruz-Mosso, Ulises
    Francisco Munoz-Valle, Jose
    Parra-Rojas, Isela
    INVESTIGACION CLINICA, 2014, 55 (03): : 266 - 277
  • [10] Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with Type 1 diabetes mellitus
    Martin, R. J. L.
    Savage, D. A.
    Carson, D. J.
    McKnight, A. J.
    Maxwell, A. P.
    Patterson, C. C.
    DIABETIC MEDICINE, 2010, 27 (02) : 143 - 149